$CCO

WELLS SCOTT sold (to issuer) $14.7M of CCO

WELLS SCOTT (Chief Executive Officer) sold (to issuer) 6,042,485 shares of Clear Channel Outdoor Holdings, Inc. (CCO) at $2.43 ($14.68M total) on 2026-10-14.

Original reporting
SEC EDGAR · WELLS SCOTT
Published Oct 15, 2026, 7:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 15, 2026, 7:31 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CCO
Neutral
medium confidence
Mentioned
$CCO
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CCONeutralLow
01

Why it matters

The disclosure updates the market on an executive’s post-transaction holdings (0 shares remaining) and the transaction size, which can influence short-term sentiment but does not, by itself, change fundamentals.

02

Market read

Traders may briefly reassess sentiment around CCO due to the CEO’s large sale, but there is no accompanying guidance, deal, or operational catalyst in the text.

03

What to watch

No 10b5-1 plan is cited, but the transaction code D and “sold to issuer” structure can still be mechanically driven rather than sentiment-driven.

Relevance 6/10Novelty 5/10Timing: today’s SEC Form 4 filing disclosure (filed 2026-10-15)

Background

The article is an SEC Form 4 insider transaction report for Clear Channel Outdoor Holdings, Inc., filed by CEO Wells Scott.

Company-level read

Ticker impact

$CCONeutralMedium confidence
Context

Clear Channel Outdoor CEO Wells Scott sold 6,042,485 shares to the issuer for about $14.68M at $2.43/share, leaving 0 shares after the trade.

Expected impact

Likely limited, short-lived pressure as traders note the large CEO sale, with most impact fading absent additional company-specific catalysts.

Evidence & confidence

The filing is a primary Form 4 disclosure, but it does not include a 10b5-1 plan and provides no accompanying operational or guidance change; insider sales often have mixed interpretation.

Market effects

Minimal sector read-through; this is an issuer-specific insider transaction without disclosed operational impact.

No clear regional spillover beyond the single US-listed name.

None indicated.

Counterpoint

The sale is to the issuer (often buyback participation or similar mechanics) and may be routine, so it may not reflect bearish expectations.

Key entities

  • Clear Channel Outdoor Holdings, Inc.

    US-listed company whose CEO executed a large sale to the issuer, per SEC Form 4.

  • WELLS SCOTT

    Chief Executive Officer and director who sold 6,042,485 shares at $2.43/share.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

Med

Cameco’s Westinghouse Stake Could Be Worth More Than $24.5 Billion

Cameco (CCO) shares rose 3.6% on reports that its co-owned Westinghouse is targeting a $50B US IPO, potentially valuing Cameco's 49% stake at over $24.5B. Cameco's Q2 earnings showed a Westinghouse net loss, but the company attributes this to project-related revenue fluctuations. Westinghouse's adjusted EBITDA fell to C$163M in Q2 from C$352M a year earlier. Cameco's P/E ratio has not significantly re-rated following the IPO news, with estimates ranging from $15B to $50B for Westinghouse.

$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).